🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Missed #THT2025? From the latest in congestion management to #LVAD science and innovative tech in the pipeline, Journal of Cardiac Failure has you covered. Check out highlights from the meeting now online 👇🏽 onlinejcf.com/article/S1071-… Elena Donald Shazli Khan Alexander Hajduczok, MD 🇺🇦🙏 Anu Lala-Trindade Robert Mentz, MD

#THT was packed with innovation in pharmacologic and device-based therapies for patients living with heart failure. Check out our highlights in Journal of Cardiac Failure in case you missed it! 🫀🛜 onlinejcf.com/article/S1071-… Aditi Nayak Alexander Hajduczok, MD 🇺🇦🙏 Rachel Goodman Shazli Khan Anu Lala-Trindade Robert Mentz, MD

An NHLABI workshop summary of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to Action. Sean Pinney Anu Lala-Trindade Jennifer Cowger Stavros George Drakos Aditi Nayak Ryan J Tedford MD Jeff Teuteberg Thomas Hanff pubmed.ncbi.nlm.nih.gov/39908057/

Have papers on heart transplantation 🫀 that are looking for a 🏡? We want your work at Journal of Cardiac Failure! ⭐️Quick turn-around for initial decision ⭐️Court of appeals ⭐️Great visibility Submit today! Robert Mentz, MD Anu Lala-Trindade Shashank Sinha, MD, MSc, FACC, FAHA, FHFSA Jeff Teuteberg Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

Heartiest congratulations on an incredible #Match2025 result for the graduates of my alma mater. A bright future lies ahead. #MatchDay2025 #MedTwitter

Behind every award is a patient who trusted us with their life. So proud to be a part of the Baylor Scott & White Dallas-Fort Worth cardiac transplant team that just won the 2025 #INTERLINK Chairman’s award for being the nations top performing 🫀transplant program.

Join our group and get connected, speak on the podium and write wonderful papers. witmcs.com

Texas Chapter - ACC Kamala Tamirisa MD Shelley Hall Congratulations to Dr. Tamirisa Kamala Tamirisa MD on her new role as President-Elect! 🎉 A well-deserved transition of leadership. Thank you, Dr. Hall Shelley Hall for your outstanding service and dedication. Best of luck to both as you continue to lead the Texas Chapter forward!

Indescribable to give #HF rounds for the Brigham and Women's Hospital Brigham & Women's CV Fellows on the Future of Durable #MCS. Certainly a full circle to talk about innovation in the field, and pay tribute to the advances already made; with the team to whom I owe my foundations and passion. #Grateful

The GRS on Assisted Circulation is coming up soon! Check out the program 👉 grc.org/assisted-circu… 💡If you haven’t applied yet, there’s still time — the deadline is May 10. 🙏Reposts appreciated!

📣📣 Join us to learn ‘Scientific Strategies to Maximize Life & Minimize #PGD in #LVAD Patients Bridged to🫀Transplant” 📆 Saturday, April 26th 🕰️ 600 pm EST 📍 Rochambeau at Hynes Convention Center, 900 Boylston Street, Boston, MA 02115.

Super pumped to be talking on a topic that keeps me up at night with this all-⭐️ crew. I hope you’ll join! The discussion promises to be 🔥. Details in link below 👇🏽 Women in Heart Transplantation and MCS Jennifer Cowger Ellen Roche MIT Seraina Dual Anu Lala-Trindade Silia DeFilippis MD FACC FAHA FHFSA Manreet Kanwar Vanessa Blumer, MD, FACC

Getting pumped for the Gordon Research Seminar on Assisted Circulation! 📢Early career researchers - deadline to apply is May 10! #MCS #Cardiotwitter #LVAD #ECMO #Unloading ⚡️Full agenda and apply here: grc.org/assisted-circu… 🙏Reposts appreciated

From temporary #MCS devices with expanding indications in #cardiogenicshock to durable #LVAD trials, management of #cardiorenalsyndrome, and hemodynamic management with #GDMT for #LVAD candidates, Baylor Scott & White Health is at the forefront of innovation in MCS! Shelley Hall

Tecafarin vs Warfarin: TEC-LVAD trial 🩸A novel vitamin K antagonist Ivan Netuka #ISHLT2025

Results from VAD WEAN multicenter retrospective registry: 491 patients underwent LVAD explant after a median of 1.2 year, 361 (73.4%) were alive at a median of 4.4 years after explant..20% patients ultimately required heart replacement tx (transplant or redo VAD). #ISHLT2025

🔥🔥 Masterful debate on #AI in organ matching & allocation between our fearless leader Shelley Hall & the brilliant #DrAndreasZuckermann Deep expertise, engaging debate 👏👏👏

Why Are Women Still Being Left Behind in Heart Failure Care? Join us Monday, May 12th at 7:00 PM CST for the first session of the WiTMCS #AHF Therapies in Women Webinar Series Cindy M. Martin Eileen Hsich #SharonBethLarson Aditi Nayak

Last reminder on this happening TONIGHT 👇🏽 Come join like-minded clinicians and scientists for a robust discussion on advancing HF care for 🙋🏻‍♀️🙋🏽‍♀️🙋‍♀️ ⏱️7pm Central 📍Virtual, link : us06web.zoom.us/j/85014839280?… Women in Heart Transplantation and MCS Abbott

🚨LATE-BREAKING DATA this weekend at #HeartFailure2025. Nir Uriel, MD MSc presented a comparative analysis on 2-year survival outcomes for #HeartMate3 LVAD and HTx patients <50 showing a 12% reduced mortality when measured from time of HM3 implant compared to death or delisting from